These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3069209)

  • 21. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics].
    Komajda M
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():13-6. PubMed ID: 10830083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure.
    McMurray J; Lang CC; Maclean DD; McDevitt DG; Struthers AD
    Scott Med J; 1989 Apr; 34(2):425-7. PubMed ID: 2740888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure].
    Hoyen HA; Alpert JS
    Cardiology; 1993; 82 Suppl 1():3-19. PubMed ID: 8519018
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function].
    Osterziel KJ; Dietz R; Kübler W
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1082-5. PubMed ID: 2661192
    [No Abstract]   [Full Text] [Related]  

  • 29. [Converting enzyme inhibitors and cardiac insufficiency: current findings and perspectives].
    Cohen-Solal A; Laperche T; Makowski S; Aumont MC
    Rev Prat; 1990 Oct; 40(23 Suppl):43-51. PubMed ID: 2267565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin-converting enzyme inhibitors in heart failure].
    Gullestad L; Søyland E; Dolva LO; Kjekshus J
    Tidsskr Nor Laegeforen; 1987 Sep; 107(25):2112-6. PubMed ID: 2823410
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
    Dietz R; Nagel F; Osterziel KJ
    Verh Dtsch Ges Inn Med; 1991; 97():545-8. PubMed ID: 1667051
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of heart failure. II. Therapy of chronic heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):36-8, 41-5. PubMed ID: 9280747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of ACE inhibitors in heart failure (clinical aspects)].
    Riegger AJ
    Z Kardiol; 1992; 81 Suppl 4():93-6. PubMed ID: 1290309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasodilators for heart failure--useful or useless?
    Franciosa JA
    Cardiology; 1988; 75 Suppl 1():110-7. PubMed ID: 3069208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there any difference between angiotensin converting enzyme inhibitors and angiotensin receptor blockers for heart failure?
    Rain C; Rada G
    Medwave; 2015 Jul; 15 Suppl 1():e6177. PubMed ID: 26247213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators?
    Massie BM
    Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
    Toher CA; Francis GS
    Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.